International Scientific Symposium "Polycondensation 2016"

The 11th International Symposium "Polycondensation 2016" was full of so many exciting scientific reports. I was honoroed to be presenting our vision for nanomedicinal drug delivery platforms delivering hope to so many patients suffering of brain tumours.

Presenting "Nano-medicine for effecient chemotherapy of Brain tumours: from bench to bedside"

The nanoparticle-based formulation of doxorubicin (working name “Nanodox”) is a novel drug

candidate against glioblastoma based on brain delivery by poly (lactide-co-glycolide) (PLGA

NPs) nanoparticles. Nanodox is being developed by R-Pharm Group (Russia) through its

research-oriented subsidiary - Drugs Technology LLC.

The 11th International Symposium "Polycondensation 2016" was held from September 11–15, 2016, in Moscow and St. Petersburg, Russia. This conference continued the tradition of focusing on the synthesis, structure, and properties of polymers formed via polycondensation methods.

公益社団法人日本化学会 +3

Key Aspects of Polycondensation 2016:

• Location & Venue: The event was organized by the A.N. Nesmeyanov Institute of Organoelement Compounds of the Russian Academy of Sciences (INEOS RAS).

• Topics Covered: The symposium covered various aspects of modern polymer chemistry, including the cyclization and dispersity of polyesters, modified epoxy oligomers, and high-performance polymers.

• Scientific Contribution: Selected papers from the conference were published in specialized scientific literature, including High Performance Polymers (Volume 29, Issue 5) and Macromolecular Symposia.

• Key Discussions: Specific topics highlighted in the abstracts included the study of unsaturated polyketones, post-consumer PET recycling, and the synthesis of epoxyphosphazenes.Sage Journals +8

This conference is part of a series of scientific meetings dedicated to the advancements in polymer synthesis and condensation reactions, often bringing together international researchers to discuss industrial and academic trends.